Moderna

News

FDA tightens heart tox warnings on mRNA COVID vaccines

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity.

News

There's good news for RSV jab firms at delayed ACIP meeting

GSK and Pfizer could see a resurgence in sales of their RSV vaccines if new recommendations at a CDC expert meeting are confirmed by agency leaders.

News

GSK rides out vaccine sales weakness with cancer, HIV gains

Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to £40 billion in 2031.

News

11 blockbuster drugs to look out for in 2025

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

Market Access

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

The pharmaceutical industry operates under a complex regulatory landscape, balancing government oversight with self-imposed standards.

News

vaccine vial held by hands in surgical green gloves

MSD, Moderna start phase 3 adjuvant lung cancer trial

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-sta

FDA tightens heart tox warnings on mRNA COVID vaccines

There's good news for RSV jab firms at delayed ACIP meeting

GSK rides out vaccine sales weakness with cancer, HIV gains

11 blockbuster drugs to look out for in 2025

Moderna’s missteps spotlight PMCPA’s role in upholding pharm...

MSD, Moderna start phase 3 adjuvant lung cancer trial

Agios mulls early FDA filing for sickle cell therapy

Using AI-driven synthetic personas to take your insights fur...

Moderna

Editor's Picks